Announcements Trials

Browse Landscape

Phase

Status

Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Malignant Female Reproductive System Neoplasm 1

Interventions

zanubrutinib 1 osimertinib 1 Vincristine 1 Trastuzumab 1 Rituximab 1 Quality of Life 1 Prednisone 1 Nutritional Status 1 Microscopy, Confocal 1 Interviews as Topic 1 Heparin 1 Exercise 1 Erlotinib Hydrochloride 1 Epirubicin 1 Enoxaparin 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER_GOV × Enoxaparin × Clear all

NCT01356329 2016-05-13

Lovenox

National Guard Health Affairs

Phase 3 Suspended

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡